November 2, 2016
India’s Ajanta gets green light for its high blood pressure generic
Ajanta Pharma has gotten US FDA’s approval to launch its high blood pressure tablets Amlodipine
Pharmaceuticals, Biotechnology and Life Sciences
Category: news
November 2, 2016
Shire doubles third quarter revenues, operates with net loss in Q3
Shire doubles third quarter revenues, operates with net loss in Q3
November 2, 2016
India’s Koanna gets UK’s MHRA OK for Imatinib tablets
India’s Koanna gets marketing approval from MHRA for Imatinib tablets
November 2, 2016
Chronix Biomedical looking to distinguish prostate cancer from BPH and prostatitis
Chronix Biomedical looking to distinguish prostate cancer from BPH and prostatitis
November 1, 2016
Pfizer to discontinue two ongoing cardiovascular studies
Pfizer announced today the discontinuation of the global clinical development program for bococizumab…
November 1, 2016
Allergan closes down Tobira purchace
Allergan has completed the acquisition of Tobira Therapeutics
November 1, 2016
Novartis gets FDA Priority Review for first-line treatment of advanced breast cancer
Novartis gets FDA Priority Review for first-line treatment of HR+/HER2-advanced breast cancer
November 1, 2016
USFDA opens door to $30M market for India’s Strides Shasun’s HIV-1 infection tablets
India’s Strides Shasun Limited has received approval from the USFDA for Abacavir Tablets
November 1, 2016
Avacta’s Affimer molecules can be used as therapeutics
Avacta Group will present detailed data from the first pre-clinical in-vivo studies of its therapeutic Affimer platform
November 1, 2016
Advanced Oncotherapy sees board changes
Advanced Oncotherapy has announced that Lord David Evans has stepped down